A retrosynthetic biology approach to therapeutics: From conception to delivery

Current Opinion in Biotechnology

Volumn 23, Issue 6, 2012, Pages 948-956

  Planson, Anne Gaëlle ^a   Carbonell, Pablo ^a   Grigoras, Ioana ^a   Faulon, Jean Loup ^a  

^a UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL PATHWAY; BIOSYNTHETIC PATHWAY; CHEMICAL BUILDING BLOCKS; DESIGN CONCEPT; METABOLIC NETWORK; RENEWABLE RESOURCE; RETROSYNTHETIC ANALYSIS; SYNTHETIC DESIGN; SYSTEMS BIOLOGY; THERAPEUTIC APPLICATION;

CHEMICAL COMPOUNDS; OPTIMIZATION;

BIOLOGY;

ARTEMISININ; BERBERINE; CODEINE; ISOPRENOID; MORPHINE; NARINGENIN; NATURAL PRODUCT; PALMATINE; TAXADIENE; UNCLASSIFIED DRUG;

AEDES AEGYPTI; ANOPHELES GAMBIAE; ARTIFICIAL INSEMINATION; BACTERIAL INFECTION; BACTERIOPHAGE M13; CANDIDA ALBICANS; CATALYSIS; CELL STRAIN HEK293; DENGUE; DIABETES MELLITUS; DRUG DESIGN; DRUG SYNTHESIS; ENTERITIS; ESCHERICHIA COLI; GENE EXPRESSION; HELA CELL; MALARIA; METABOLIC ENGINEERING; NEOPLASM; NONHUMAN; ORAL MUCOSITIS; PRIORITY JOURNAL; QUORUM SENSING; RETROSYNTHETIC BIOLOGY; REVIEW; SALMONELLA ENTERICA; STAPHYLOCOCCUS EPIDERMIDIS; SYSTEMS BIOLOGY; T LYMPHOCYTE; THERMODYNAMICS; TUMOR LYSIS SYNDROME;

ANIMALS; BIOSYNTHETIC PATHWAYS; DRUG DISCOVERY; HUMANS; SYNTHETIC BIOLOGY;

EID: 84869862664     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2012.03.009     Document Type: Review

References (58)

1. Lee J.W., Kim T.Y., Jang Y.S., Choi S., Lee S.Y. Systems metabolic engineering for chemicals and materials. Trends Biotechnol 2011, 29:370-378.
2. Nielsen J., Keasling J.D. Synergies between synthetic biology and metabolic engineering. Nat Biotechnol 2011, 29:693-695.
3. Planson A.G., Carbonell P., Grigoras I., Faulon J.L. Engineering antibiotic production and overcoming bacterial resistance. Biotechnol J 2011, 6:812-825.
4. Brunk E., Neri M., Tavernelli I., Hatzimanikatis V., Rothlisberger U. Integrating computational methods to retrofit enzymes to synthetic pathways. Biotechnol Bioeng 2012, 109:572-582.
5. Carbonell P., Planson A.G., Fichera D., Faulon J.L. A retrosynthetic biology approach to metabolic pathway design for therapeutic production. BMC Syst Biol 2011, 5:122.
6. Cho A., Yun H., Park J.H.H., Lee S.Y.Y., Park S. Prediction of novel synthetic pathways for the production of desired chemicals. BMC Syst Biol 2010, 4:35.
7. Bachmann B.O. Biosynthesis: is it time to go retro?. Nat Chem Biol 2010, 6:390-393.
8. Cook A., Johnson P., Law J., Mirzazadeh M., Ravitz O., Simon A. Computer-aided synthesis design: 40 years on. WIREs Comput Mol Sci 2012, 2:79-107.
9. Aurand T.C., Russell M.S., March J.C. Synthetic signaling networks for therapeutic applications. Curr Opin Biotechnol 2012, 10.1016/j.copbio.2012.1001.1001.
10. Westfall P.J., Pitera D.J., Lenihan J.R., Eng D., Woolard F.X., Regentin R., Horning T., Tsuruta H., Melis D.J., Owens A., et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A 2012, 109:E111-E118.
11. Keasling J.D. Synthetic biology and the development of tools for metabolic engineering. Metab Eng 2012, 10.1016/j.ymben.2012.1001.1004.
12. Ajikumar P.K., Xiao W.H., Tyo K.E., Wang Y., Simeon F., Leonard E., Mucha O., Phon T.H., Pfeifer B., Stephanopoulos G. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74.
13. Yu L.H., Wei X., Ma M., Chen X.J., Xu S.B. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm. Antimicrob Agents Chemother 2012, 56:770-775.
14. Gomes F., Teixeira P., Cerca N., Azeredo J., Oliveira R. Effect of farnesol on structure and composition of Staphylococcus epidermidis biofilm matrix. Curr Microbiol 2011, 63:354-359.
15. Joo J.H., Jetten A.M. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett 2010, 287:123-135.
16. Wang C., Yoon S.H., Shah A.A., Chung Y.R., Kim J.Y., Choi E.S., Keasling J.D., Kim S.W. Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway. Biotechnol Bioeng 2010, 107:421-429.
17. Santos C.N., Koffas M., Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab Eng 2011, 13:392-400.
18. Nakagawa A., Minami H., Kim J.S., Koyanagi T., Katayama T., Sato F., Kumagai H. A bacterial platform for fermentative production of plant alkaloids. Nat Commun 2011, 2:326.
19. Lee T.S., Krupa R.A., Zhang F., Hajimorad M., Holtz W.J., Prasad N., Lee S.K., Keasling J.D. BglBrick vectors and datasheets: a synthetic biology platform for gene expression. J Biol Eng 2011, 5:12.
20. Dale J., Popescu L., Karp P. Machine learning methods for metabolic pathway prediction. BMC Bioinform 2010, 11:15.
21. Planson A.G., Carbonell P., Paillard E., Pollet N., Faulon J.L. Compound toxicity screening and structure-activity relationship modeling in Escherichia coli. Biotechnol Bioeng 2012, 109:846-850.
22. Weber W., Fussenegger M. Molecular diversity-the toolbox for synthetic gene switches and networks. Curr Opin Chem Biol 2011, 15:414-420.
23. Carbonell P., Fichera D., Pandit S., Faulon J.L. Enumerating metabolic pathways for the production of heterologous target chemicals in chassis organisms. BMC Syst Biol 2012, 6:10.
24. Hädicke O., Klamt S. CASOP: a computational approach for strain optimization aiming at high productivity. J Biotechnol 2010, 147:88-101.
25. Ranganathan S., Suthers P.F., Maranas C.D. OptForce: an optimization procedure for identifying all genetic manipulations leading to targeted overproductions. PLoS Comput Biol 2010, 6:e1000744.
26. Kim J., Reed J.L., Maravelias C.T. Large-scale bi-level strain design approaches and mixed-integer programming solution techniques. PLoS One 2011, 6:e24162.
27. Dugar D., Stephanopoulos G. Relative potential of biosynthetic pathways for biofuels and bio-based products. Nat Biotechnol 2011, 29:1074-1078.
28. Pandit A., Mahadevan R. In silico characterization of microbial electrosynthesis for metabolic engineering of biochemicals. Microb Cell Fact 2011, 10:76.
29. Na D., Kim T.Y.Y., Lee S.Y.Y. Construction and optimization of synthetic pathways in metabolic engineering. Curr Opin Microbiol 2010, 13:363-370.
30. Lynch S.A., Gill R.T. Synthetic biology: new strategies for directing design. Metab Eng 2011, 10.1016/j.ymben.2011.1012.1007.
31. Kazlauskas R.J., Bornscheuer U.T. Finding better protein engineering strategies. Nat Chem Biol 2009, 5:526-529.
32. Yuzawa S., Kim W., Katz L., Keasling J.D. Heterologous production of polyketides by modular type I polyketide synthases in Escherichia coli. Curr Opin Biotechnol 2012, 10.1016/j.copbio.2011.1012.1029.
33. Bumpus S.B., Evans B.S., Thomas P.M., Ntai I., Kelleher N.L. A proteomics approach to discovering natural products and their biosynthetic pathways. Nat Biotechnol 2009, 27:951-956.
34. Fischbach M., Voigt C.A. Prokaryotic gene clusters: a rich toolbox for synthetic biology. Biotechnol J 2010, 5:1277-1296.
35. Zhang H., Jiang T. Synthetic circuits, devices and modules. Protein Cell 2010, 1:974-978.
36. Karlsson M., Weber W. Therapeutic synthetic gene networks. Curr Opin Biotechnol 2012, 10.1016/j.copbio.2012.1001.1003.
37. Ruder W.C., Lu T., Collins J.J. Synthetic biology moving into the clinic. Science 2011, 333:1248-1252.
38. Weber W., Fussenegger M. Emerging biomedical applications of synthetic biology. Nat Rev Genet 2012, 13:21-35.
39. Ye H., Daoud-El Baba M., Peng R.W., Fussenegger M. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 2011, 332:1565-1568.
40. Xie Z., Wroblewska L., Prochazka L., Weiss R., Benenson Y. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 2011, 333:1307-1311.
41. Kemmer C., Gitzinger M., Daoud-El Baba M., Djonov V., Stelling J., Fussenegger M. Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat Biotechnol 2010, 28:355-360.
42. Saeidi N., Wong C.K., Lo T.M., Nguyen H.X., Ling H., Leong S.S., Poh C.L., Chang M.W. Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol Syst Biol 2011, 7:521.
43. Rollié S., Mangold M., Sundmacher K. Designing biological systems: systems engineering meets synthetic biology. Chem Eng Sci 2012, 69:1-29.
44. Lu T.K., Collins J.J. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A 2009, 106:4629-4634.
45. Chen J., Yang B., Cheng X., Qiao Y., Tang B., Chen G., Wei J., Liu X., Cheng W., Du P., et al. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model. Cancer Sci 2012, 103:325-333.
46. Royo J.L., Becker P.D., Camacho E.M., Cebolla A., Link C., Santero E., Guzman C.A. In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit. Nat Methods 2007, 4:937-942.
47. Duan F., Curtis K.L., March J.C. Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes. Appl Environ Microbiol 2008, 74:7437-7438.
48. Caluwaerts S., Vandenbroucke K., Steidler L., Neirynck S., Vanhoenacker P., Corveleyn S., Watkins B., Sonis S., Coulie B., Rottiers P. AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol 2010, 46:564-570.
49. Hamady Z.Z., Scott N., Farrar M.D., Wadhwa M., Dilger P., Whitehead T.R., Thorpe R., Holland K.T., Lodge J.P., Carding S.R. Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-beta1 under the control of dietary xylan 1. Inflamm Bowel Dis 2011, 17:1925-1935.
50. Duan F., March J.C. Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model. Proc Natl Acad Sci U S A 2010, 107:11260-11264.
51. Hebert C.G., Gupta A., Fernandes R., Tsao C.Y., Valdes J.J., Bentley W.E. Biological nanofactories target and activate epithelial cell surfaces for modulating bacterial quorum sensing and interspecies signaling. ACS Nano 2010, 4:6923-6931.
52. Fernandes R., Roy V., Wu H.C., Bentley W.E. Engineered biological nanofactories trigger quorum sensing response in targeted bacteria. Nat Nanotechnol 2010, 5:213-217.
53. Wise de Valdez M.R., Nimmo D., Betz J., Gong H.F., James A.A., Alphey L., Black WCt Genetic elimination of dengue vector mosquitoes. Proc Natl Acad Sci U S A 2011, 108:4772-4775.
54. Windbichler N., Menichelli M., Papathanos P.A., Thyme S.B., Li H., Ulge U.Y., Hovde B.T., Baker D., Monnat R.J., Burt A., et al. A synthetic homing endonuclease-based gene drive system in the human malaria mosquito. Nature 2011, 473:212-215.
55. Culler S.J., Hoff K.G., Smolke C.D. Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 2010, 330:1251-1255.
56. Nissim L., Bar-Ziv R.H. A tunable dual-promoter integrator for targeting of cancer cells. Mol Syst Biol 2010, 6:444.
57. Chen Y.Y., Jensen M.C., Smolke C.D. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc Natl Acad Sci U S A 2010, 107:8531-8536.
58. Kemmer C., Fluri D.A., Witschi U., Passeraub A., Gutzwiller A., Fussenegger M. A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms. J Control Release 2011, 150:23-29.